It is difficult to predict when exactly a generic version of the lower strength of Alphagan P will become available. Both strengths have the exact same patents listed with the United States Food and Drug Administration (the first of which is currently set to expire in December 2012). It is unclear why only one strength is available in generic form.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 21, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click